Description
Scope of the Report The report titled “ US Thyroid Cancer Market : Trends and Opportunities ( 2015-2019 )” provides an insight into the overall thyroid cancer market of the United States of America . The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries , Thyroid Histopathology Market , Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market . The report assesses thyroid cancer types , stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market . Further , companies like Veracyte Inc ., Mylan Inc ., Forest Laboratories , Abott Laboratories and Oxigene Inc . are profiled in the report .
Request a sample of this report @ http :// www . orbisresearch . com / contacts / request-sample / 185273 .
Product Coverage Thyroid Cancer Diagnostic Surgeries Thyroid Cancer Histopathology Market Thyroid Cancer Secondary Surgery Thyroid Cancer Hormone Replacement FNA biopsies
Company Coverage Veracyte Inc . Mylan Inc . Forest Laboratories Abott Laboratories Oxigene Inc .
Purchase a copy of US Thyroid Cancer Market visit @ http :// www . orbisresearch . com / contact / purchase / 185273 For more information contact sales @ orbisresearch . com .
Executive Summary Thyroid cancer , a type of malignant cancer , initiate from follicular and par follicular thyroid cells . The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone ( TSH ) suppression therapy . Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer . Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise . Incidence has more than doubled since the early 1970s , and for women , it is the cancer with the fastest-growing number of new cases .
On the back of high incidence of thyroid cancer , it is anticipated that the thyroid cancer market in US will observe impressive double digit growth in next five years . The thyroid cancer diagnosis market is segmented into diagnostic surgeries , histopathology , secondary surgery and annual new patient hormone replacement therapy . The diagnostic technology has improved since 2011 and with use of Afirma GEC test and Afirma FNA ; the detection of even minor nodules has become possible .
www . orbisresearch . com ; + 1 ( 214 ) 884-6817 ; + 9120-64101019